Blood Test for Colon Cancer Screening is Approved by U.S. Regulators

The FDA has approved the Shield blood test for colon cancer screening, marking a significant advancement in noninvasive testing. Suitable for adults aged 45 and older with average risk, this test detects DNA fragments from tumor cells and precancerous growths.

 

Although it doesn't replace colonoscopies, it offers an alternative for those deterred by the invasive preparation and scheduling hassles. In a recent study, it identified 83% of cancers but missed some precancerous lesions. Read more from the AP here.